Schnurr, Max <br/><br/>
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling.  [electronic resource] 

 -  Blood  Jul 2003 
 - 613-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2002-12-3745  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--pharmacology<br/>Antigens, CD1--analysis<br/>Calcium Signaling--drug effects<br/>Chemotaxis--drug effects<br/>Dendritic Cells--classification<br/>Depression, Chemical<br/>Dermis--cytology<br/>Dinoprostone--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Resistance<br/>Glycoproteins--analysis<br/>Humans<br/>Inflammation<br/>Interferon-alpha--pharmacology<br/>Melanoma--blood<br/>Membrane Proteins--pharmacology<br/>Monocytes--cytology<br/>Phosphatidylinositol Diacylglycerol-Lyase<br/>RNA, Messenger--biosynthesis<br/>Receptors, Interleukin-3--analysis<br/>Receptors, Purinergic P2--biosynthesis<br/>Signal Transduction--drug effects<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Type C Phospholipases--physiology